In patients with an ongoing AE-COPD, UPF1 and UPF17 significantly increased COX-2 expression (p = 0.027 and p = 0.049, respectively) (Figure 1B, left panel; Table 3). Here, PTGS2 is linked to chronic obstructive pulmonary disease.